{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:48:21Z","timestamp":1791856101361,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.steroids.2007.10.003","type":"journal-article","created":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T14:31:29Z","timestamp":1194618689000},"page":"222-231","source":"Crossref","is-referenced-by-count":140,"title":["Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile"],"prefix":"10.1016","volume":"73","author":[{"given":"Shinichi","family":"Sasagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuka","family":"Mita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Imada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.steroids.2007.10.003_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/gye.15.s6.22.28","article-title":"Current place of progestins in the treatment of endometriosis-related complaints","volume":"15","author":"Schweppe","year":"2001","journal-title":"Gynecol Endocrinol"},{"issue":"Suppl. C","key":"10.1016\/j.steroids.2007.10.003_bib2","first-page":"3","article-title":"The preclinical and clinical profile of dienogest. A short overview","volume":"35","author":"Oettel","year":"1999","journal-title":"Drugs Today"},{"issue":"Suppl. 1","key":"10.1016\/j.steroids.2007.10.003_bib3","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"issue":"1A","key":"10.1016\/j.steroids.2007.10.003_bib4","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1016\/S0002-9343(99)80067-9","article-title":"The androgenicity of progestins","volume":"98","author":"Darney","year":"1995","journal-title":"Am J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.steroids.2007.10.003_bib5","first-page":"21","article-title":"The role of antiandrogens in hormone replacement therapy","volume":"3","author":"Schneider","year":"2000","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.steroids.2007.10.003_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1783\/147118903101197188","article-title":"Newer progestogens","volume":"29","author":"Rowlands","year":"2003","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"4","key":"10.1016\/j.steroids.2007.10.003_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"issue":"13","key":"10.1016\/j.steroids.2007.10.003_bib8","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00002512-200421130-00004","article-title":"New progestogens: a review of their effects in perimenopausal and postmenopausal women","volume":"21","author":"Sitruk-Ware","year":"2004","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.steroids.2007.10.003_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0010-7824(80)90140-7","article-title":"STS 557, a new orally active progestin with antiprogestational and contragestational properties in rabbits","volume":"21","author":"Oettel","year":"1980","journal-title":"Contraception"},{"issue":"7","key":"10.1016\/j.steroids.2007.10.003_bib10","first-page":"517","article-title":"A 19-norprogestin without 17\u03b1-ethinyl group II: dienogest from a pharmacodynamic point of view","volume":"31","author":"Oettel","year":"1995","journal-title":"Drugs Today"},{"issue":"2","key":"10.1016\/j.steroids.2007.10.003_bib11","first-page":"45","article-title":"Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid","volume":"23","author":"Katsuki","year":"1997","journal-title":"Drugs Exp Clin Res"},{"issue":"Suppl. C","key":"10.1016\/j.steroids.2007.10.003_bib12","first-page":"41","article-title":"The treatment of endometriosis with dienogest","volume":"35","author":"Moore","year":"1999","journal-title":"Drugs Today"},{"issue":"4","key":"10.1016\/j.steroids.2007.10.003_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0015-0282(01)03270-8","article-title":"Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study","volume":"77","author":"Cosson","year":"2002","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.steroids.2007.10.003_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09513590500431482","article-title":"High-dose pilot study with the novel progestogen dienogest in patients with endometriosis","volume":"22","author":"Schindler","year":"2006","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.steroids.2007.10.003_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/humupd\/dmi049","article-title":"Advances in the management of endometriosis: an update for clinicians","volume":"12","author":"Crosignani","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.steroids.2007.10.003_bib16","first-page":"324","article-title":"Effect of antiandrogens on some key enzymes of glycolysis in epididymis and ventral prostate of rat","volume":"27","author":"Gupta","year":"1989","journal-title":"Indian J Exp Biol"},{"issue":"2","key":"10.1016\/j.steroids.2007.10.003_bib17","first-page":"173","article-title":"Further report on the endocrinological profile of 17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9(10)-diene-3-one (STS 557) in rodents","volume":"79","author":"Koch","year":"1982","journal-title":"Endokrinologie"},{"issue":"2","key":"10.1016\/j.steroids.2007.10.003_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0029-1210229","article-title":"Receptor binding of STS 557","volume":"81","author":"Kaufmann","year":"1983","journal-title":"Exp Clin Endocrinol"},{"issue":"1\/2","key":"10.1016\/j.steroids.2007.10.003_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0029-1210897","article-title":"Pharmacokinetics of the progestin dienogest (STS 557) in rabbits","volume":"94","author":"Hillesheim","year":"1989","journal-title":"Exp Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.steroids.2007.10.003_bib20","first-page":"545","article-title":"Normal and stable transfected cancer cell lines: tools for a screening of progestogenic, antiprogestogenic and antiglucocorticoid substances","volume":"16","author":"Sobek","year":"1994","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.steroids.2007.10.003_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0006-291X(02)00564-8","article-title":"Stabilization of androgen receptor protein is induced by agonist, not by antagonists","volume":"294","author":"Furutani","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.steroids.2007.10.003_bib22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1210\/me.14.6.889","article-title":"Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1)","volume":"14","author":"Fuse","year":"2000","journal-title":"Mol Endocrinol"},{"issue":"11","key":"10.1016\/j.steroids.2007.10.003_bib23","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1128\/MCB.22.11.3698-3706.2002","article-title":"Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex","volume":"22","author":"Kitagawa","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"21","key":"10.1016\/j.steroids.2007.10.003_bib24","doi-asserted-by":"crossref","first-page":"15645","DOI":"10.1074\/jbc.M000042200","article-title":"p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A\/B domains","volume":"275","author":"Kobayashi","year":"2000","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.steroids.2007.10.003_bib25","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","article-title":"Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B","volume":"9","author":"Kastner","year":"1990","journal-title":"Embo J"},{"issue":"6099","key":"10.1016\/j.steroids.2007.10.003_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/325075a0","article-title":"Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor","volume":"325","author":"Green","year":"1987","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.steroids.2007.10.003_bib27","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/j.1460-2075.1989.tb03604.x","article-title":"The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties","volume":"8","author":"Tora","year":"1989","journal-title":"EMBO J"},{"issue":"23","key":"10.1016\/j.steroids.2007.10.003_bib28","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1093\/nar\/13.23.8293","article-title":"Cloning of the human glucocorticoid receptor cDNA","volume":"13","author":"Govindan","year":"1985","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.steroids.2007.10.003_bib29","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0092-8674(87)90581-2","article-title":"Functional domains of the human estrogen receptor","volume":"51","author":"Kumar","year":"1987","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.steroids.2007.10.003_bib30","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/nar\/30.6.1387","article-title":"Transcriptional regulation of the mouse steroid 5alpha-reductase type II gene by progesterone in brain","volume":"30","author":"Matsui","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"46","key":"10.1016\/j.steroids.2007.10.003_bib31","doi-asserted-by":"crossref","first-page":"42684","DOI":"10.1074\/jbc.M107844200","article-title":"The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes","volume":"276","author":"Yamamoto","year":"2001","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.steroids.2007.10.003_bib32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0039-128X(79)90090-4","article-title":"Measurement of the testosterone binding parameters for both testosterone-estradiol binding globulin and albumin in individual serum samples","volume":"34","author":"Nisula","year":"1979","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2007.10.003_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1113\/jphysiol.1934.sp003217","article-title":"The assay of progestin","volume":"83","author":"McPhail","year":"1934","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.steroids.2007.10.003_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02627727","article-title":"Hormonal contraceptives and carbohydrate tolerance. II. Influence of medroxyprogesterone acetate and chronic oral contraceptives","volume":"10","author":"Vermeulen","year":"1974","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.steroids.2007.10.003_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0010-7824(85)90074-5","article-title":"Long-term effects of Depo-Provera on carbohydrate and lipid metabolism","volume":"31","author":"Liew","year":"1985","journal-title":"Contraception"},{"issue":"3 Pt 2","key":"10.1016\/j.steroids.2007.10.003_bib36","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0002-9378(93)90335-G","article-title":"Effects of desogestrel on carbohydrate metabolism","volume":"168","author":"Shoupe","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.steroids.2007.10.003_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00016348409157000","article-title":"Plasma lipoproteins during and after danazol treatment","volume":"123","author":"Fahraeus","year":"1984","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"issue":"4","key":"10.1016\/j.steroids.2007.10.003_bib38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0002-9378(83)90311-3","article-title":"Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis","volume":"145","author":"Luciano","year":"1983","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.steroids.2007.10.003_bib39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0015-0282(16)49277-0","article-title":"Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate","volume":"45","author":"Fahraeus","year":"1986","journal-title":"Fertil Steril"},{"issue":"1\u20132","key":"10.1016\/j.steroids.2007.10.003_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0029-1210899","article-title":"Carbohydrate metabolism during treatment of endometriosis with the progestin dienogest","volume":"94","author":"Nikschick","year":"1989","journal-title":"Exp Clin Endocrinol"},{"issue":"23","key":"10.1016\/j.steroids.2007.10.003_bib41","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/hc4801.099737","article-title":"Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor","volume":"104","author":"Herkert","year":"2001","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.steroids.2007.10.003_bib42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s001980200080","article-title":"Pharmacologic doses of medroxyprogesterone may cause bone loss through glucocorticoid activity: an hypothesis","volume":"13","author":"Ishida","year":"2002","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.1016\/j.steroids.2007.10.003_bib43","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/en.142.9.3791","article-title":"A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER \u03b1","volume":"142","author":"Larrea","year":"2001","journal-title":"Endocrinology"},{"issue":"1\/2","key":"10.1016\/j.steroids.2007.10.003_bib44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mce.2003.10.030","article-title":"Drospirenone, a progestogen with antimineralocorticoid properties: a short review","volume":"217","author":"Oelkers","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2007.10.003_bib45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0022-4731(81)90319-8","article-title":"The significance of drug interactions with human TeBG and CBG under physiological conditions: a new approach","volume":"15","author":"Pugeat","year":"1981","journal-title":"J Steroid Biochem"},{"issue":"1","key":"10.1016\/j.steroids.2007.10.003_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0015-0282(16)46395-8","article-title":"Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity","volume":"38","author":"Nilsson","year":"1982","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.steroids.2007.10.003_bib47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)46941-4","article-title":"Free testosterone levels during danazol therapy","volume":"39","author":"Nilsson","year":"1983","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.steroids.2007.10.003_bib48","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2265.1986.tb03614.x","article-title":"Dosage-related effects of danazol on sex hormone binding globulin and free and total androgen levels","volume":"25","author":"Forbes","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.steroids.2007.10.003_bib49","first-page":"499","article-title":"A 19-norprogestin without a 17\u03b1-ethinyl group I: dienogest from a pharmacokinetic point of view","volume":"31","author":"Oettel","year":"1995","journal-title":"Drugs Today"},{"issue":"6","key":"10.1016\/j.steroids.2007.10.003_bib50","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0015-0282(16)48612-7","article-title":"Effects of progesterone, progestogens, and danazol on the specific cortisol binding in human plasma","volume":"43","author":"Ottosson","year":"1985","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.steroids.2007.10.003_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-4347(00)86126-5","article-title":"Determination of 20\u03b1-hydroxy-9\u03b2,10\u03b1-pregna-4,6- dien-3-one in plasma by selected ion monitoring","volume":"272","author":"Takasu","year":"1983","journal-title":"J Chromatogr"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X07002012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X07002012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T17:30:00Z","timestamp":1684085400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X07002012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0039128X07002012"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2007.10.003","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}